CompletedNot Applicable

Treatment of Wounds Using Oasis® ECM

United Kingdom41 participantsStarted 2021-03-01

Plain-language summary

The purpose of this clinical study is to gather post-market clinical evidence on the use of Oasis ECM as a treatment for donor site wounds in the community setting in the United Kingdom.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Age \< 18 years
✕. Unable or unwilling to provide informed consent
✕. Unable or unwilling to comply with the study follow-up schedule, and procedures
✕. Simultaneously participating in another investigational drug or device study
✕. Target wound area is \< 2 cm2 or \> 140 cm2 after baseline debridement
✕. Target wound has reduced in area by \> 40% with 4 weeks of documented standard of care therapy
✕. Known allergy to pig or porcine products
✕. Systemic infection

What they're measuring

Wound healing

Timeframe: 12 weeks

Trial details

NCT IDNCT03632031

SponsorCook Biotech Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Non-healing Wound trials